UNION therapeutics A/S: Financial statements 2022
CVR: 33963750
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 34,393,000 and a net result of DKK -214,304,000 compared with DKK -56,026,000 the year before. That is a decrease of 71.1% compared with the year before. The profit margin was -623.1%. Equity in the 2022 report amounted to DKK -27,688,000.
- Revenue
- DKK 34,393,000
- Profit/Loss
- DKK -214,304,000
- Equity
- DKK -27,688,000
- Total Assets
- DKK 185,675,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 34.4M | - | -214.3M | -27.7M | - |
| 2021 | 118.9M | - | -56M | 49.4M | 26 |
| 2020 | 0 | - | -80.9M | -58.4M | - |
| 2019 | 11.6M | - | -12.9M | -38.3B | - |
| 2018 | 0 USD | - | -7.8M USD | -5.3M USD | - |
Official annual report
Keep an eye on UNION therapeutics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
UNION therapeutics A/S has published its annual report for 2021. Revenue came to DKK 118,912,000, and the net result was DKK -56,026,000.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.